LLY
Eli Lilly and Company
LLY's fundamentals are strong: revenue grew 46% and it turned 23% of its revenue into free cash flow. At 46x earnings, it's trading in line with its usual 48x. Analysts expect that strong growth to continue.
WULF
TeraWulf Inc.
There isn't enough reported data to score WULF yet.
LLY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.
WULF Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| N/A | |
| N/A |
WULF's revenue is currently healthy, but its profitability is weak. Free cash flow and net leverage aren't meaningful measures for financial services companies like WULF.
LLY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 27x | $845 | -41% |
| Forward | 30x | $1,427 | — |
| Current | 46x | $1,427 | — |
| Fair | 48x | $1,466 | +2.7% |
| Expensive | 85x | $2,612 | +83% |
Historical ranges are pointers, not guarantees.
LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.
WULF PE Valuation
WULF has no meaningful PE right now: it lost money over the past year.
LLY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for LLY, with profitability improving.
WULF Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect WULF's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
LLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $46.82 | +52% |
| Q3 2026 | $30.81 | +51% |
| Q2 2026 | $29.80 | +95% |
| Q1 2026 | $28.15 | +129% |
| Q4 2025 | $22.95 | +96% |
| Q3 2025 | $20.44 | +121% |
| Q2 2025 | $15.30 | +88% |
| Q1 2025 | $12.29 | +81% |
| Q4 2024 | $11.71 | +102% |
LLY has the edge over WULF on earnings quality, reporting a profit while its opponent remains loss making.
WULF Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.30 | -$1.87 |
| Q2 2026 | -$4.40 | -$4.04 |
| Q1 2026 | -$2.51 | -$2.17 |
| Q4 2025 | -$1.66 | -$1.45 |
| Q3 2025 | -$1.43 | -$1.29 |
| Q2 2025 | -$0.36 | -$0.19 |
| Q1 2025 | -$0.34 | -$0.12 |
| Q4 2024 | -$0.21 | +$0.14 |
WULF lost $3.30 per share over the past year, a bigger loss than the year before.
LLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.4B | +39% |
| Q2 2026 | $23B | +48% |
| Q1 2026 | $19.8B | +56% |
| Q4 2025 | $19.3B | +43% |
| Q3 2025 | $17.6B | +54% |
| Q2 2025 | $15.6B | +38% |
| Q1 2025 | $12.7B | +45% |
| Q4 2024 | $13.5B | +45% |
LLY has the edge over WULF on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -6.6 points |
| Q2 2026 | 40% | -3.3 points |
| Q1 2026 | 45% | +18 points |
| Q4 2025 | 43% | +5.6 points |
| Q3 2025 | 41% | +27 points |
| Q2 2025 | 44% | +12 points |
| Q1 2025 | 27% | -1.8 points |
| Q4 2024 | 37% | +10 points |
LLY has the edge over WULF on profitability, with a higher operating margin.
WULF Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $76.2M | +51% |
| Q2 2026 | $44.8M | -6% |
| Q1 2026 | $34M | -1.1% |
| Q4 2025 | $35.8M | +2.4% |
| Q3 2025 | $50.6M | +87% |
| Q2 2025 | $47.6M | +34% |
| Q1 2025 | $34.4M | -19% |
| Q4 2024 | $35M | +50% |
WULF's revenue is growing: $76M last quarter, up 51% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -116% | -67 points |
| Q2 2026 | -314% | -281 points |
| Q1 2026 | -477% | -303 points |
| Q4 2025 | -241% | -94 points |
| Q3 2025 | -49% | +9.3 points |
| Q2 2025 | -33% | -14 points |
| Q1 2025 | -173% | -168 points |
| Q4 2024 | -147% | -127 points |
WULF's operating margin was −116% last quarter, down 67 points from the same quarter a year ago.
LLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.2B | +22% |
| Q2 2026 | $7.8B | +458% |
| Q1 2026 | $3B | +1826% |
| Q4 2025 | $677.9M | -31% |
| Q3 2025 | $6.7B | +186% |
| Q2 2025 | $1.4B | +476% |
| Q1 2025 | $156.1M | -13% |
| Q4 2024 | $977.8M | +$2.4B |
LLY has the edge over WULF on cash generation, producing positive trailing cash flow while its opponent burns cash.
WULF Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$876.9M | -$608.7M |
| Q2 2026 | -$992.3M | -$817.5M |
| Q1 2026 | -$540.5M | -$503.3M |
| Q4 2025 | -$703.2M | -$506.8M |
| Q3 2025 | -$268.3M | -$226.6M |
| Q2 2025 | -$174.8M | -$144.5M |
| Q1 2025 | -$37.2M | -$13.1M |
| Q4 2024 | -$196.4M | -$173.5M |
WULF's free cash flow was −$3.1B over the past year, against −$677M the year before. Free cash flow isn't a meaningful measure for financial services companies like WULF.
LLY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -300K shares |
| 1 year | -0.6% | -5.4M shares |
| 3 years | -0.7% | -6.4M shares |
| 5 years | -1.9% | -17.4M shares |
| Available history | -4.5% | -42.3M shares |
LLY has the edge over WULF on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $377M |
| Q2 2026 | $1.6B |
| Q1 2026 | $2.4B |
| Q4 2025 | $1.5B |
| Q3 2025 | $708.1M |
| Q2 2025 | $692.2M |
| Q1 2025 | $1.2B |
| Q4 2024 | $2.1B |
LLY spent $5.8B buying back its own shares over the past year, up 26% from the year before.
WULF Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +18% | +87.9M shares |
| 1 year | +43% | +172M shares |
| 3 years | +173% | +363M shares |
| 5 years | +28923% | +572M shares |
| Available history | +28866% | +572M shares |
WULF has 574M diluted shares, up 43% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $33.3M |
| Q4 2021 | — |
WULF hasn't bought back shares in the past year.
LLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.1x | Moderate |
LLY's net debt is about 1.2 years of its operating earnings (EBITDA), about the same as a year ago.
WULF Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2024 | -1.0x | Net Cash |
| Q2 2024 | -1.4x | Net Cash |
| Q1 2024 | 3.5x | Elevated |
| Q4 2021 | 32.9x | High |
WULF has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like WULF.
LLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 84.1 | Overbought |
LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).
WULF Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.6 | Neutral |
| Stochastic | 24.3 | Neutral |
WULF's weekly RSI is 41 (neutral) and its Stochastic is 24 (neutral).
LLY PE vs Healthcare Sector
| Metric | LLY | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 26x | 79% above |
| PE % | 48 | 29 | 19 pts above |
LLY is trading at 46x earnings, a 79% premium to the Healthcare sector's median of 26x.
WULF PE vs Financial Services Sector
| Metric | WULF | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
WULF has no meaningful PE right now: it lost money over the past year.
LLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,279.4 | 12% above |
| 20 week MA | $1,218.8 | 17% above |
| 50 week MA | $1,102.2 | 29% above |
| 100 week MA | $954.1 | 50% above |
| 200 week MA | $797.5 | 79% above |
LLY has the edge over WULF on trend strength, trading above more of its moving averages.
WULF Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $13.0 | 0.2% above |
| 20 week MA | $15.9 | 18% below |
| 50 week MA | $17.1 | 24% below |
| 100 week MA | $11.9 | 9.7% above |
| 200 week MA | $7.29 | 79% above |
WULF's trend is mixed: it's above three of its five weekly moving averages, and 79% above its 200-week average.
LLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $131.5 | $166.7 | +27% |
| 2021 | $166.7 | $273.1 | +64% |
| 2022 | $273.1 | $367.9 | +35% |
| 2023 | $367.9 | $582.9 | +58% |
| 2024 | $582.9 | $783.2 | +34% |
| 2025 | $783.2 | $1,077.8 | +38% |
| 2026 YTD | $1,077.8 | $1,427.3 | +32% |
LLY has the edge over WULF on returns for 2026, with the stronger performance.
WULF Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.42 | $6.48 | +20% |
| 2021 | $6.48 | $14.4 | +122% |
| 2022 | $14.4 | $0.77 | -95% |
| 2023 | $0.77 | $2.40 | +212% |
| 2024 | $2.40 | $5.53 | +130% |
| 2025 | $5.53 | $11.8 | +112% |
| 2026 YTD | $11.8 | $13.0 | +11% |
WULF's yearly returns have swung widely, from +212% in 2023 to −95% in 2022. It's up 11% so far in 2026.